chartexchange

MLTX
MoonLake Immunotherapeutics Class A
stockNASDAQ

Market OpenNov 19, 2026 3:11:30 PM EST
11.01USD+2.039%(+0.22)835,617
Pre-marketNov 19, 2026 9:28:30 AM EST
10.75USD-0.371%(-0.04)
11.02Bid12.59Ask1.57Spread

MLTX Financials

In Q3 FY 2026 (ended ), MoonLake Immunotherapeutics Class A (MLTX) reported net income of −$79.55M, operating cash flow of −$63.4M, and assets of $540.72M (filed ).

Loading financial statements…